Abstract
Caffeine is the oldest consumed psychoactive drug, present in coffee, cocoa, tea, among other products. Several conventional methods are used to analyze caffeine, for example, chromatography and spectrometry, but these methods are expensive when compared to electroanalytical methods. The objective of this study is to study the feasible applicability of electrochemical techniques for quantification of caffeine in medications. Cyclic voltammetry was performed on the platinum electrode in 0.5 M H2SO4 and after that differential pulse voltammetry was performed to obtain the linear relation between caffeine concentration and current. A linear response in the electroanalytical approach exists from 38.05±3.02 to 192.39±1.04 ppm with a limit of detection of about 9.09±0.72 ppm. This sensor may represent a new analytical tool for caffeine analysis, based on existing literature.
Keywords: Caffeine, platinum sensor, cyclic voltammetry, drugs.
Current Pharmaceutical Analysis
Title:Platinum Sensor for Quantifying Caffeine in Drug Formulations
Volume: 10 Issue: 4
Author(s): Danyelle Medeiros de Araujo, Chrystiane do Nascimento Brito, Severina Denise Sales de Oliveira, Djalma Ribeiro da Silva, Carlos A. Martinez-Huitle and Cícero Flavio Soares Aragao
Affiliation:
Keywords: Caffeine, platinum sensor, cyclic voltammetry, drugs.
Abstract: Caffeine is the oldest consumed psychoactive drug, present in coffee, cocoa, tea, among other products. Several conventional methods are used to analyze caffeine, for example, chromatography and spectrometry, but these methods are expensive when compared to electroanalytical methods. The objective of this study is to study the feasible applicability of electrochemical techniques for quantification of caffeine in medications. Cyclic voltammetry was performed on the platinum electrode in 0.5 M H2SO4 and after that differential pulse voltammetry was performed to obtain the linear relation between caffeine concentration and current. A linear response in the electroanalytical approach exists from 38.05±3.02 to 192.39±1.04 ppm with a limit of detection of about 9.09±0.72 ppm. This sensor may represent a new analytical tool for caffeine analysis, based on existing literature.
Export Options
About this article
Cite this article as:
Araujo Medeiros de Danyelle, Brito do Nascimento Chrystiane, de Oliveira Sales Severina Denise, Silva Ribeiro da Djalma, Martinez-Huitle A. Carlos and Aragao Flavio Soares Cícero, Platinum Sensor for Quantifying Caffeine in Drug Formulations, Current Pharmaceutical Analysis 2014; 10 (4) . https://dx.doi.org/10.2174/1573412910666140630191329
DOI https://dx.doi.org/10.2174/1573412910666140630191329 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases
Current Drug Therapy Mineralocorticoid Receptor Antagonism and Cardiac Remodeling in Ischemic Heart Failure
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Therapeutic Potential of Nitrate Esters of Commonly Used Drugs
Current Topics in Medicinal Chemistry Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine
Current Pharmaceutical Analysis Effect of Grapefruit Juice in Relation to Human Pharmacokinetic Study
Current Clinical Pharmacology The Roles of Corticotropin Releasing Factor (CRF) in Responses to Emotional Stress: Is CRF Release a Cause or Result of Fear/Anxiety?
CNS & Neurological Disorders - Drug Targets Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry Cardioprotective Potential of Iron Chelators and Prochelators
Current Medicinal Chemistry Crystallization and Preliminary Crystallographic Studies of an Antitumour Lectin from the Edible Mushroom Agrocybe aegerita
Protein & Peptide Letters Peptides for In Vivo Target-Specific Cancer Imaging
Mini-Reviews in Medicinal Chemistry Oligonucleotide-based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs
Current Drug Targets The Role of Cnidaria in Drug Discovery. A Review on CNS Implications and New Perspectives
Recent Patents on CNS Drug Discovery (Discontinued) Monoclonal Antibodies as Cancer Therapeutics
Recent Patents on Biotechnology State of the Art Management of Transfusion-Related Acute Lung Injury (TRALI)
Current Pharmaceutical Design A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response, an Update
Current Medicinal Chemistry Acute Hypersensitivity Reactions to Chemotherapy Agents: An Overview
Inflammation & Allergy - Drug Targets (Discontinued) Perception of Symptoms in Hypertensive Patients and the Relevance to the Application of Anti- Hypertensive Drug Therapy
Current Pharmaceutical Design Chemotherapy and Delivery in the Treatment of Primary Brain Tumors
Current Clinical Pharmacology Advances Towards The Discovery of GPR55 Ligands
Current Medicinal Chemistry Current Evidence Regarding Low-carb Diets for The Metabolic Control of Type-2 Diabetes
Current Diabetes Reviews